RevMAb 2021 FEATURED PRODUCTS
RevMAb 2021 NEW PRODUCTS
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.Learn more about our technology ABOUT US!
Variant Specific mAb-AR Variant 7, EGFR Variant III